Premium International Injectable advances pharmaceutical manufacturing ambitions in Sri Lanka
This story is no longer in the live feed. First reported .
Daily Mirror, Lankadeepa and Newswire report that Sri Lanka’s first insulin manufacturing plant is expected or planned to begin production in 2027. Daily Mirror and Lankadeepa attribute the planned start to Health and Mass Media Minister Nalinda Jayatissa.
Daily Mirror reports that production is expected to follow completion of construction and the required validation processes. Newswire reports that the project involves an investment of more than Rs. 3 billion.
Ada Derana (தமிழ்) and Newswire report that Premium International Injectable (Private) Limited is developing a pharmaceutical manufacturing facility in Sri Lanka. Ada Derana (தமிழ்) says the project is intended to strengthen local manufacturing capacity and support future growth in the pharmaceutical sector.
Written automatically by AI from the outlets’ own reports, and not reviewed by an editor. It can be wrong — the original report is the authority.
Earlier coverage
Reports on the same subject from the months before this story.